Researchers have identified a promising way to weaken one of pancreatic cancer’s key defenses against treatment. The approach focuses on blocking IL1RAP, a receptor that plays a central role in
A large study led by Rutgers researchers has identified a possible vision risk associated with widely used diabetes and weight loss medications, including Ozempic and Wegovy. The findings suggest that
Researchers at Duke-NUS Medical School have discovered a molecular “switch” that determines whether pancreatic cancer cells respond to chemotherapy or resist it. The finding points to a way to potentially
A new study from Brazil, published in the journal Molecular and Cellular Endocrinology, sheds light on how pancreatic cancer gains the ability to spread at an early stage. Researchers found
Scientists at Northwestern have uncovered a clever trick that helps pancreatic cancer hide from the immune system — and a potential way to stop it. Pancreatic cancer remains one of
For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels become extremely low, it creates a life-threatening situation for which the
Surveillance programs for people at high risk of developing pancreatic cancers can help detect precancerous conditions and cancers early, when they are most treatable, according to a new multicenter study
Relapse presents a major barrier to recovery from substance use disorders — when people begin taking drugs such as cocaine again after a period of abstinence. Sleep disruptions have long
Pancreatic cancer has few treatment options and limited survival, with only 9% of patients still living five years after diagnosis. But a detailed analysis of pancreatic cancer by researchers at
Detailed characterization of human pancreatic islets is key to elucidate the pathophysiology of all forms of diabetes mellitus, including its most common form known as type 2 diabetes (T2D). However,
